Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Muta M. Issa, MD, MBA

Articles by Muta M. Issa, MD, MBA

Comparative Analysis of Alpha-blocker Utilization in Combination With 5-Alpha Reductase Inhibitors for Enlarged Prostate in a Managed Care Setting Among Medicare-aged Men

ByMuta M. Issa, MD, MBA,Pei-Jung Lin, PhD,Michael T. Eaddy, PharmD, PhD,Manan B. Shah, PharmD, PhD,E. Anne Davis, PharmD, MS

May 1st 2008

A Large Retrospective Analysis of Acute Urinary Retention and Prostate-related Surgery in BPH Patients Treated with 5-alpha Reductase Inhibitors: Dutasteride Versus Finasteride

ByMuta M. Issa, MD, MBA,M. Chris Runken, PharmD,Amy L. Grogg, PharmD,Manan B. Shah, PharmD, PhD

February 1st 2007

Medical Therapy for Benign Prostatic Hyperplasia - Present and Future Impact

ByMuta M. Issa, MD, MBA,Timothy S. Regan, BPharm, RPh, CPh

February 1st 2007

Clinical and Economic Outcomes in Patients Treated for Enlarged Prostate

ByMichael James Naslund, MD, MBA,Muta M. Issa, MD, MBA,Amy L. Grogg, PharmD,Michael T. Eaddy, PharmD, PhD,Libby Black, PharmD

March 1st 2006

An Assessment of the Diagnosed Prevalence of Diseases in Men 50 Years of Age or Older

ByMuta M. Issa, MD, MBA,Thomas C. Fenter, MD,Libby Black, PharmD,Amy L. Grogg, PharmD,Eric J. Kruep, PharmD, MS

March 1st 2006

Latest Updated Articles

Comparative Analysis of Alpha-blocker Utilization in Combination With 5-Alpha Reductase Inhibitors for Enlarged Prostate in a Managed Care Setting Among Medicare-aged Men
Published: May 1st 2008 | Updated:
Clinical and Economic Outcomes in Patients Treated for Enlarged Prostate
Published: March 1st 2006 | Updated:
An Assessment of the Diagnosed Prevalence of Diseases in Men 50 Years of Age or Older
Published: March 1st 2006 | Updated:
A Large Retrospective Analysis of Acute Urinary Retention and Prostate-related Surgery in BPH Patients Treated with 5-alpha Reductase Inhibitors: Dutasteride Versus Finasteride
Published: February 1st 2007 | Updated:
Medical Therapy for Benign Prostatic Hyperplasia - Present and Future Impact
Published: February 1st 2007 | Updated:

Trending on AJMC

In Primary Care–Oncology Collaboration, the Baton Goes Both Ways

FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer

FDA Expands Evinacumab-dgnb Approval for Children as Young as 1 Year With HoFH

Marathon Health, Medbridge Partner to Launch Integrated Virtual MSK Care Program

Myasthenia Gravis–Induced Fears of Diagnosed Patients During the Pandemic

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

© 2025 MJH Life Sciences^®

All rights reserved.